Tangier disease
Tangier disease (TD) is a genetic disorder of cholesterol transport
named for the secluded island of Tangier, located off the coast of Virginia.
TD was first identified in a five-year-old inhabitant of the island who had
characteristic orange tonsils, very low levels of high density lipoprotein
(HDL) or 'good cholesterol', and an enlarged liver and spleen.
TD is caused by mutations in the ABC1 (ATP-binding cassette)
gene on chromosome 9q31. ABC1 codes for a protein that helps rid cells of
excess cholesterol. This cholesterol is then picked up by HDL particles in
the blood and carried to the liver, which processes the cholesterol to be
reused in cells throughout the body. Individuals with TD are unable to eliminate
cholesterol from cells, leading to its buildup in the tonsils and other organs.
The discovery of this important cholesterol transport gene may
lead to a better understanding of the inverse relationship between HDL levels
and coronary artery disease, an important killer in the US. New drugs that
regulate HDL levels may be developed and such drugs would not only help individuals
with TD, but also people with more common disorders such as familial HDL deficiency.
This is a good illustration of how research into rare diseases can sometimes
help more common disorders.